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The Relationship Between Rave Drug Use and Executive Functioning
PSYC 292, Research in Addictive Behaviors, Fall 2020
Malaika Malik

BACKGROUND
• MDMA/Ecstasy, also known as “rave” or “party”
drugs have become popular amongst young adults
• Little is known or confirmed about the effects of
MDMA/Ecstasy
• Studies have shown evidence in favor of deficits
in executive functioning that is linked to the use of
the drug
• Depressive symptoms could be related to
MDMA/Ecstasy use, but exploration as to how is
required
• Age could be a potential contributor to worsening
deficits in executive functioning
• This study aimed to explore these variables and if
there is an relationship between these variables

TA B L E S

STUDY DESIGN AND PROCEDURE
• Participants were recruited via social
media outreach and on Clark University’s
campus (n = 31)
• Consenting participants took an online
survey to self report on the measures
• Data was scored accordingly, and mean
scores were determined
• A correlational analysis was run to
determine a relationship between:
• Substance involvement and depression
• Substance involvement and executive
functioning
• Substance involvement, age, and
executive functioning with the
covariate of depression

Table 1
Means and standard deviation of all measure variables based on total score and age in
years.
Variable

Mean

SD

1. Substance Involvement

1.00

2.08

2. CES-D[A]

23.93

14.80

3. DEX

25.65

21.86

4. Webexec

12.03

4.61

5. Barratt

62.33

10.37

6. Age in Years

21.58

2.85

Table 2
Intercorrelations between total score of measure of individual measures for Substance
Involvement and subsequent measures of executive functioning, depression, age
demographics, with the control for impulsiveness.
Measures

2

3

4

5

6

-

.409*

.546**

.416*

.452*

.551**

2. CES-D[A]

-

-

.825**

.654**

.637**

-.043

3. DEX

-

-

-

.798**

.814**

-.039

4. Webexec

-

-

-

-

.751**

-.057

5. Barratt

-

-

-

-

-

.189

6. Age in

-

-

-

-

-

-

1. Substance

1

Involvement

MEASURES
•

There were 5 measures used to assess
the variables:
•
•
•
•

Substance Involvement Screening Test
was used to determine MDMA/Ecstasy
use history
CES-D[A] was used to determine selfreported depressive symptoms
DEX and Webexec were used to assess
self-reported deficits in executive
functioning
Barratt Impulsiveness Scale was used as
a control measure for impulsiveness

R E S U LT S
• Results indicated that there was a
significant positive correlation between
MDMA/Ecstasy use and executive
functioning
• Based on scoring methods, it was revealed
that use of rave drugs is correlated to deficits
in executive functioning

• Participants who were involved with
the consumption of MDMA/Ecstasy
showed deficits in executive
functioning, as well as a relationship
with depression
• Hypothesis regarding negative effects
of MDMA/Ecstasy use on executive
functioning was supported

Years
**Correlation is significant at the 0.01 level (2-Tailed)
*Correlation is significant at the 0.05 level (2-Tailed)

DISCUSSION
• The hypothesis of the study was supported
by the results
• Limitations:
•
•
•

Small participant pool
Measures were all self-report
The results were significant, and are a support to
previous literatures that touch upon the negative
effects of MDMA/Ecstasy use

